<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250703066348N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-08-31</date_registration>
      <primary_sponsor>Shomal University</primary_sponsor>
      <public_title>Investigating the effect of plyometric exercises on knee muscle strength and improvement of motor performance after anterior cruciate ligament surgery</public_title>
      <acronym>ACLR</acronym>
      <scientific_title>The effect of 6 weeks of plyometric exercises on the strength of muscles around the knee and lower extremity Functional performance in male underwent Anterior cruciate ligament reconstruction: A clinical trial study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84858</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this quasi-experimental study, 30 male athletes (with a history of one ACL reconstruction within the past 6 to 12 months) who were eligible for inclusion in the study were purposively identified and then divided into two equal groups (15 in the plyometric training group and 15 in the control group) by simple randomization.

The randomization process was performed as follows:

An independent person, unaware of the study objectives, randomly generated a list of numbers from 1 to 30 using random number generation software (such as Excel or Randomizer.org).

Half of the numbers (e.g., even numbers) were assigned to the training group (Plyometric) and the other half (odd numbers) were assigned to the control group.

In order to prevent any bias, the assignment of subjects to groups was done by an independent person and the researcher was unaware of the group assignment until the final list was completed (allocation concealment).

During the randomization process, inclusion and exclusion criteria were predetermined, and only those who met all inclusion criteria were included in this allocation, Blinding description: 1. Blinded Outcome Assessor:
All outcome measurements, including isokinetic strength assessments of the quadriceps and hamstrings, as well as functional performance tests of the lower extremity (e.g., single-leg hop tests), will be conducted by a trained assessor who is completely blinded to the participants’ group allocation.

The outcome assessor will not be involved in the intervention phase and will only participate in the pre-test and post-test assessments. Participants will be instructed not to disclose their group assignment or any intervention details during testing. All assessments will be performed under standardized conditions (time, location, and equipment) for all participants.

 2. Blinded Data Analyst:
The collected data will be coded (e.g., as Group A and Group B) before statistical analysis. The data analyst will be blinded to the actual group identities throughout the entire analysis process. Group codes will only be revealed after statistical comparisons and interpretations are completed.</study_design>
      <phase>2</phase>
      <hc_freetext>Anterior Cruciate Ligament Reconstruction.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group : Participants in the intervention group will undergo a supervised plyometric training program for 6 weeks, with 3 sessions per week (approximately 50 minutes per session: 5 min warm-up, 40 min training, 5 min cool-down).Exercises include single- and double-leg jumps, forward-backward hopping, lateral hopping, vertical jumps, and zigzag patterns. The intensity and complexity of the exercises will be progressively increased through three planned phases. Intervention 2: Control group: Participants in the control group will not receive any additional intervention during the 6-week study period. They will continue their usual daily activities, team practices, or general physical routines without any structured plyometric training.Weekly follow-up (by phone or in-person) will be conducted to ensure adherence and confirm no major changes in physical activity.Pre- and post-intervention assessments will be performed identically to the intervention group.At the end of the study, participants will be offered access to the training protocol if interested.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Due to ethical considerations and the need to protect the confidentiality of participants’ personal information, individual-level raw data will not be made publicly available. Sharing such data could potentially lead to identification of participants even after anonymization</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Reza Rezaeian vaskasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imamzadeh Abdullah Crossroads, 5th km of Haraz Road, Amol City ,Mazandaran Province</address>
        <city>Amol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۴۶۱۶۱۸۴۵۹۶</zip>
        <telephone>+98 11 4420 3711</telephone>
        <email>rezaeianr7@gmail.com</email>
        <affiliation>shomal university</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Komeil Dashti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Mazandaran, University Boulevard , Babolsar City , Mazandaran Province</address>
        <city>Babolsar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۳۵۳۴ – ۴۷۴۱۶</zip>
        <telephone>+98 11 3530 2801</telephone>
        <email>kdr_140@yahoo.com</email>
        <affiliation>University of Mazandaran</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Males aged 18-35 years
Confirmation of ACL reconstruction (patellar and hamstring tendon autograft) by a knee specialist with radiographs and MRI
No history of back or lower extremity surgery (other than knee)
ACL reconstruction history at least 6 months and no more than 12 months ago</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Concomitant injury or surgery to other knee ligaments or structures
Injury or surgery in other lower limb joints (hip, ankle)
Neuromuscular or cardiovascular disorders limiting exercise participation
Participation in other rehabilitation or training programs within the past 3 months
Non-adherence (absence from &gt;2 training or testing sessions)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S83.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sprain of cruciate ligament of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group : Participants in the intervention group will undergo a supervised plyometric training program for 6 weeks, with 3 sessions per week (approximately 50 minutes per session: 5 min warm-up, 40 min training, 5 min cool-down).Exercises include single- and double-leg jumps, forward-backward hopping, lateral hopping, vertical jumps, and zigzag patterns. The intensity and complexity of the exercises will be progressively increased through three planned phases.</i_keyword>
      <i_keyword>Control group: Participants in the control group will not receive any additional intervention during the 6-week study period. They will continue their usual daily activities, team practices, or general physical routines without any structured plyometric training.Weekly follow-up (by phone or in-person) will be conducted to ensure adherence and confirm no major changes in physical activity.Pre- and post-intervention assessments will be performed identically to the intervention group.At the end of the study, participants will be offered access to the training protocol if interested.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>1. Quadriceps muscle strength: measured with an isokinetic device at a 6-degree angle, recording normalized torque based on body weight. Timepoint: Quadriceps muscle strength will be measured once before the start of the intervention (week 0) and once immediately after the end of the training period (week 6). Method of measurement: Quadriceps muscle strength is assessed using an isokinetic machine at an angular velocity of 60 degrees/second. After sitting on the machine seat, the subject extends the knee with maximum force, and the maximum torque produced (in Newton meters/kg) is recorded.</prim_outcome>
      <prim_outcome>1. hamstring muscle strength: measured with an isokinetic device at a 6-degree angle, recording normalized torque based on body weight. Timepoint: hamstring muscle strength will be measured once before the start of the intervention (week 0) and once immediately after the end of the training period (week 6). Method of measurement: Hamstring muscle strength is assessed using an isokinetic device at an angular velocity of 60 degrees/second. After sitting on the device seat, the subject flexes the knee with maximum force, and the maximum torque produced (in Newton meters/kg) is recorded.</prim_outcome>
      <prim_outcome>2. Hamstring to quadriceps muscle strength ratio: measured with an isokinetic device at an angular velocity of 60 degrees, recording normalized torque based on body weight. Timepoint: The ratio of hamstring to quadriceps muscle strength will be measured once before the start of the intervention (week 0) and once immediately after the end of the training period (week 6). Method of measurement: The hamstring to quadriceps strength ratio (H/Q Ratio) is obtained by dividing the hamstring muscle torque by the quadriceps muscle torque (in the 60-degree isokinetic test).</prim_outcome>
      <prim_outcome>4. Single-leg jump test with both legs, measuring jump distance with a tape measure. Timepoint: Single-leg  measurements will be measured once before the start of the intervention (week 0) and once immediately after the end of the training period (week 6). Method of measurement: Single-leg hop: The subject jumps forward with one leg and lands on the same leg. The longest distance of the successful jump is recorded.</prim_outcome>
      <prim_outcome>5. Triple jump test with both legs, measuring the jump distance with a tape measure. Timepoint: triple-leg hop: The subject jumps forward with one leg and lands on the same leg. The longest distance of the successful jump is recorded. Method of measurement: Triple jump: Three consecutive jumps on one leg, maintaining balance at the end, and measuring the total distance traveled. The jump distance is measured with a tape measure on the ground and in centimeters.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice President for Research, Shomal University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-06-28</approval_date>
        <contact_name>Shahrood University of Technology Research Ethics Committee</contact_name>
        <contact_address>Shahrood University of Technology,Haft Tir Square, Shahrood , Semnan, Iran Shahrood Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
